Covaxin phase 3 trial to begin on November 20, Minister Anil Vij offers to be 1st volunteer Ruchika Sharma19 Nov 2020 12:19 PM ISTChandigarh: Haryana Health Minister Anil Vij on Wednesday said the third phase of trial of Covaxin, a potential vaccine against COVID-19, will begin...
Delhi: Data shows Non-COVID beds decreasing fast at many hospitals Medical Dialogues Bureau19 Nov 2020 9:15 AM ISTAt Max hospital, Patparganj; Batra hospital; Fortis hospital, Shalimar Bagh; and Fortis Escorts Heart Institute, all non COVID19 ICU beds were...
Face masks don't hinder vigorous exercise performance in healthy individuals Hina Zahid18 Nov 2020 6:49 PM ISTA new University of Saskatchewan (USask) study has found that exercise performance and blood and muscle oxygen levels are not affected for healthy...
COVID antibody test in 10 mins: Cipla launches Covi-G for COVID-19 rapid antibody detection Ruchika Sharma18 Nov 2020 3:02 PM ISTMumbai: Drug major, Cipla Limited, today announced that the company signed a licensing agreement with a Belgium- based firm, Multi G for the...
Russian COVID vaccine could be produced in China, India: Putin Ruchika Sharma18 Nov 2020 1:14 PM ISTMoscow: President Vladimir Putin on Tuesday called for a joint effort by the Brics countries on the development of Covid-19 vaccines as he suggested...
India in dialogue with Moderna, other biotech firms over progress in COVID vaccine development: Sources Ruchika Sharma18 Nov 2020 11:25 AM ISTNew Delhi: India is in dialogue with the US-based biotech giant Moderna over the progress in the clinical trials of its coronavirus vaccine candidate,...
Over 100 scientists join hands with UN to bust Covid-19 vaccine myths Medical Dialogues Bureau18 Nov 2020 11:08 AM ISTNew Delhi: Under a UN initiative, over 100 scientists have joined hands to tackle the issue of misinformation around Covid-19 vaccines and build...
Sotagliflozin reduces CVD risk in those with diabetes and kidney disease: Study Hina Zahid18 Nov 2020 10:15 AM ISTDALLAS - A novel diabetes medication significantly reduces the risk of hospitalization for heart failure, heart attack and stroke, in patients with...
Moderna's COVID-19 vaccine candidate near 95% effective, shows interim data Dr. Kamal Kant Kohli17 Nov 2020 8:15 PM ISTCAMBRIDGE, Mass.-- Moderna's candidate vaccine against COVID-19, known as mRNA-1273, has shown 94.5% efficacy in an interim analysis from its phase 3...
Biological E begins phase I, II human trials of Covid vaccine Ruchika Sharma17 Nov 2020 1:55 PM ISTHyderabad: Biological E. Limited, a Hyderabad-based vaccines and pharmaceutical company, Dynavax Technologies Corporation , a US-based vaccine focused...
Bharat Biotech Covaxin enters phase 3 trials Ruchika Sharma17 Nov 2020 1:00 PM ISTCovaxin is being developed by Bharat Biotech, in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of...
Are we suffering from "COVIDIGITALITIS"? Pawan V Kulkarni17 Nov 2020 10:36 AM ISTWe feared the first wave of COVID19 but managed to curtail the further widespread in mid of chaos. Now knowing that COVID 19 is here to stay, we...
